Solid Biosciences
SLDB
SLDB
39 hedge funds and large institutions have $74.8M invested in Solid Biosciences in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $7K
122.44% less ownership
Funds ownership: 203.04% → 80.6% (-122%)
Holders
39
Holding in Top 10
–
Calls
–
Puts
$7K
Top Buyers
| 1 | +$1.28M | |
| 2 | +$1.07M | |
| 3 | +$997K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$505K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$88.6K |
Top Sellers
| 1 | -$1.84M | |
| 2 | -$186K | |
| 3 | -$69K | |
| 4 |
Renaissance Technologies
New York
|
-$61.7K |
| 5 |
OWP
Old Well Partners
Charlotte,
North Carolina
|
-$58.1K |